LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma

Fang Cai (South San Francisco, United States of America), Fang Cai, David F. Choy, Jochen Brumm, Cecile Holweg, Alyssa Morimoto, Joseph R. Arron, John Matthews, Heleen Scheerens

Source: International Congress 2015 – Emerging strategies for airway disease treatments
Session: Emerging strategies for airway disease treatments
Session type: Thematic Poster Session
Number: 4364
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fang Cai (South San Francisco, United States of America), Fang Cai, David F. Choy, Jochen Brumm, Cecile Holweg, Alyssa Morimoto, Joseph R. Arron, John Matthews, Heleen Scheerens. LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma. Eur Respir J 2015; 46: Suppl. 59, 4364

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014

LATE-BREAKING ABSTRACT: Mast cell markers in adipose tissue, systemic inflammation and asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016


LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015


LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016


LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013

Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015

Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016

Concentration of C-reactive protein (CRP) in elderly asthmatics
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015


LATE-BREAKING ABSTRACT: Sputum transcriptome analysis yields eosinophilic and non-eosinophilic inflammatory mechanisms in UBIOPRED asthma cohort
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015

Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Evaluation of inflammatory markers IL-6 and MMP-9 in asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015


LATE-BREAKING ABSTRACT: Surfactant protein D is dysregulated in severe asthma
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014


Relation between concentration of TNF-apha, IL-6, CRP and airway hyperresponsiveness in elderly asthmatics
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

Blood eosinophils relate more closely to reduced lung function than serum ECP or plasma EDN in young asthmatics
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013

LATE-BREAKING ABSTRACT: Serum periostin as a valuable biomarker of comorbid chronic rhinosinusitis in patients with asthma
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016



LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015

Ration of IL1beta / IL1-receptor antagonist (RA) in alveolar macrophages of induced sputum of patients with asthma during long-term follow-up
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014